CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PFIZER

PFE
$143.68B
Large Cap
NASDAQPharmaceutical PreparationsPharmaceutical🇺🇸North AmericaNEW YORK75.0K employees

Pfizer Inc. (/ˈfaɪzər/ FY-zər) is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America.

Website

Drugs in Pipeline

670

Phase 3 Programs

389

Upcoming Catalysts

31

Next Catalyst

This month

Market Overview

Stock performance and key metrics

PFE News
Catalyst Timeline

39 upcoming, 4 past

Phase 2Next

PF-07220060 + PF-07104091 combination dose escalation Phase 2 Est. Readout

August 2026~STALE+IMMINENTPF-07220060 + PF-07104091 combination dose escalation192

Primary completion for PF-07220060 + PF-07104091 combination dose escalation trial (NCT05262400) in Breast Cancer

Source
Phase 3
✗Negative

Elotuzumab Phase 3 Est. Readout

August 2026~Elotuzumab492

Primary completion for Elotuzumab trial (NCT06152575) in Multiple Myeloma

Failed Phase 3 non-small cell lung cancer study

Source
Phase 2
✓Positive

ARV-471 Phase 2 Est. Readout

September 2026~Abemaciclib37

Primary completion for ARV-471 trial (NCT05548127) in Breast Cancer

Robust efficacy and favorable tolerability demonstrated; monthly dosing supported

Source

36 more catalysts beyond 14 days

Start a 48-hour free trial to see all upcoming catalysts

Pro

How PFE's past catalysts played out

Phase 3 readoutFeb 2026-2%Phase 2 readoutFeb 2026+0%PDUFA decisionSep 2025+0%earningsAug 2025+5%PDUFA decisionJul 2025+0%Data ReadoutSep 2024-10%PDUFA decisionJul 2024+3%PDUFA decisionMay 2020+0%
Drug Pipeline

FSME-IMMUN NEW 0.25 ml

Phase 3

Tick-borne Encephalitis

NWP09

Phase 3

Attention Deficit Hyperactivity Disorder

PF-07220060

Phase 3

Liposarcoma

Rimegepant (PF-07899801)

Phase 3

Acute Treatment of Migraine

13 valent Pneumococcal Conjugate Vaccine

Phase 3

Pneumococcal Infections

7vPnc pneumococcal conjugate vaccine

Phase 3

Vaccines, Pneumococcal

Bifeprunox

Phase 3

Schizophrenia

Epoetin Hospira

Phase 3

Chronic Renal Failure Requiring Hemodialysis

Sunitinib malate

Phase 3

Breast Neoplasms

Ethambutol hydrochloride

Phase 3

Mycobacterium Avium-intracellulare Infection

ritonavir

Phase 3

COVID-19

ReFacto AF

Phase 3

Hemophilia A

binimetinib

Phase 3

MSS

ropinirole

Phase 3

Parkinson Disease

Desvenlafaxine Succinate Sustained-Release

Phase 3

Major Depressive Disorder

Ceftazidime - Avibactam ( CAZ-AVI)

Phase 3

Complicated Urinary Tract Infection

Etanercept

Phase 3

Pulmonary Fibrosis

Avelumab (MSB0010718C)

Phase 3

Renal Cell Cancer

Steroids

Phase 3

Kidney Failure

rFIX

Phase 3

Hemophilia B

In open-label phase: treatment with tofacitinib

Phase 3

Arthritis Juvenile Idiopathic

Ibuprofen 600 mg ER

Phase 3

Pain

cefuroxime plus erythromycin

Phase 3

Pneumonia

PF-05280014

Phase 3

Metastatic Breast Cancer

Quillivant Oral Suspension XR

Phase 3

Attention Deficit Hyperactivity Disorder

Prevenar 13™

Phase 3

Infections, Meningococcal

Desvenlafaxine Succinate

Phase 3

Major Depressive Disorder

Enzalutamide

Phase 3

Breast Cancer

CP 690,550 5 mg

Phase 3

Psoriasis

Voriconazole

Phase 3

Neutropenia

indobufen

Phase 3

Atrial Fibrillation

PF-04965842 200 mg

Phase 3

Dermatitis

desvenlafaxine 50 mg

Phase 3

Depressive Disorder, Major

Isovorin

Phase 3

Gastric Cancer

Nirmatrelvir

Phase 3

COVID-19

Doripenem

Phase 3

Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis

Midazolam

Phase 3

Sedation

Artemether-lumefantrine

Phase 3

Malaria, Falciparum

Crizotinib

Phase 3

Non Small Cell Lung Cancer

Rapamune

Phase 3

Renal Allograft Recipients

Effexor XR

Phase 3

Depression

Fesoterodine PR 4 mg

Phase 3

Urinary Bladder, Neurogenic

desipramine

Phase 3

Depression

procarbazine hydrochloride

Phase 3

Brain and Central Nervous System Tumors

Abrocitinib 100 mg

Phase 3

Atopic Dermatitis

desvenlafaxine succinate sustained release

Phase 3

Vasomotor Symptoms

Anidulafungin, VER002

Phase 3

Aspergillosis

treatment

Phase 3

Non Squamous Lung Cancer

Tofacitinib

Phase 3

Rheumatoid Arthritis

Crisaborole 2%

Phase 3

Atopic Dermatitis

Etrasimod

Phase 3

Alopecia Areata

Elranatamab

Phase 3

Multiple Myeloma

Fenofibrate

Phase 3

Hyperlipidemia

Disease-modifying antirheumatic drug

Phase 3

Arthritis, Rheumatoid

Ritlecitinib 100 mg

Phase 3

Vitiligo

20vPnC

Phase 3

Pneumococcal Disease

Genotonorm

Phase 3

Growth Disorders

Varenicline tartrate

Phase 3

Smoking Cessation

pegaptanib sodium

Phase 3

Macular Degeneration

tanezumab 5 mg

Phase 3

Arthritis

Tanezumab 2.5 mg

Phase 3

Osteoarthritis, Knee

rLP2086 vaccine

Phase 3

Meningitis, Meningococcal

Apixaban

Phase 3

Atrial Fibrillation

Talazoparib

Phase 3

Prostate Cancer

Fx-1006A

Phase 3

Familial Amyloid Polyneuropathy

Sulfadoxine-Pyrimethamine/Chloroquine

Phase 3

PLASMODIUM FALCIPARUM MALARIA

Mefloquine

Phase 3

Malaria, Falciparum

CP 690,550

Phase 3

Rheumatoid Arthritis

PN-152,243)/PN-196,444

Phase 3

Sarcoma

Physician's-Choice

Phase 3

Breast Neoplasms

Bazedoxifene Acetate

Phase 3

Osteoporosis

PF-04965842 100 mg

Phase 3

Dermatitis, Atopic

gemcitabine hydrochloride

Phase 3

Lung Cancer

Sigvotatug Vedotin

Phase 3

Non-Small Cell Lung Cancer

Epogen Amgen

Phase 3

Chronic Renal Failure

desvenlafaxine SR

Phase 3

Depression

Standard of Care FIX Replacement therapy

Phase 3

Hemophilia B

PVC (daily for 21 days, 7 days off)

Phase 3

Atrophic Vaginitis

Dexmedetomidine HCL Injection

Phase 3

Awake Fiberoptic Intubation

Bazedoxifene/Conjugated Estrogen

Phase 3

Vaginal Atrophy

desvenlafaxine succinate sustained release tablets

Phase 3

Major Depressive Disorder

Cyclosporine

Phase 3

Kidney Transplant

Amphotericin B

Phase 3

Mycoses

Pegvisomant

Phase 3

Acromegaly

Ceftaroline

Phase 3

Community-Acquired Bacterial Pneumonia

MenACWY-TT

Phase 3

Meningococcal ACWY Disease

PF-06741086

Phase 3

Hemophilia A

Clostridium difficile vaccine

Phase 3

Clostridium Difficile Associated Disease

DVS-SR 50 mg

Phase 3

Major Depressive Disorder

Varenicline

Phase 3

Smoking

RSVpreF Vaccine

Phase 3

Respiratory Syncytial Virus

Levofloxacin

Phase 3

Community-Acquired Infections

daunorubicin + cytarabine

Phase 3

Leukemia, Myeloid, Acute

Dimebon

Phase 3

Alzheimer's Disease

PF-06801591

Phase 3

Advanced Malignancies

Desvenlafaxine Sustained Release

Phase 3

Fibromyalgia

Bacillus Calmette-Guerin

Phase 3

Non-muscle Invasive Bladder Cancer

IBU BID

Phase 3

Pain

PF-07248144

Phase 3

Breast Cancer

PF-06838435/ fidanacogene elaparvovec

Phase 3

Hemophilia B

gemtuzumab ozogamicin

Phase 3

Leukemia

13vPnC + TIV

Phase 3

Pneumococcal Infections

Zyvox® / Linezolid

Phase 3

Bacterial Infections

CP-690,550 (tofacitinib)

Phase 3

Juvenile Idiopathic Arthritis

PF-02341066

Phase 3

Carcinoma, Non-Small-Cell Lung

Antibiotic

Phase 3

Pneumonia, Pneumococcal

Sunitinib + Capecitabine

Phase 3

Breast Neoplasms

Axitinib (AG-013736)

Phase 3

Hepatocellular Carcinoma

Osivelotor

Phase 3

Sickle Cell Disease

DIC075V (intravenous diclofenac sodium)

Phase 3

Pain, Postoperative

PhXA41

Phase 3

Glaucoma

Interferon Alfa

Phase 3

Carcinoma, Renal Cell

13-valent Pneumoccocal Conjugate Vaccine

Phase 3

Pneumococcal Conjugate Vaccine

PF-08634404

Phase 3

Carcinoma, Hepatocellular

Fragmin/ Dalteparin Sodium

Phase 3

Diabetic Foot Ulcer

Temsirolimus (CCI-779)

Phase 3

Advanced Renal Cell Carcinoma

Glasdegib

Phase 3

Acute Myeloid Leukemia

Rimegepant 25 MG

Phase 3

Migraine

chemotherapy

Phase 3

Leukemia

(PN-152,243)/ PN-196,444

Phase 3

Non-Hodgkin Lymphoma

fluoxetine

Phase 3

Major Depressive Disorder

MERREM I.V. 2g as a 3 hour infusion every 8 hours

Phase 3

Pneumonia

PF-07055480 (giroctocogene fitelparovec): Recombinant AAV2/6 Human Factor VIII Gene Therapy

Phase 3

Hemophilia A

Ertapenem

Phase 3

Bacterial Infections

Inclacumab

Phase 3

Sickle Cell Disease

Dazukibart

Phase 3

Dermatomyositis

Mevrometostat

Phase 3

Metastatic Castration Sensitive Prostate Cancer (mCSPC)

Crisaborole Ointment

Phase 3

Atopic Dermatitis

Vanquix Auto-Injector (Diazepam Injection)

Phase 3

Seizures

Dexmedetomidine hydrochloride

Phase 3

Sedation

Rimegepant/BHV3000

Phase 3

Pediatric Migraine

PF-06438179

Phase 3

Rheumatoid Arthritis

Fentanyl

Phase 3

Anesthesia

Irinotecan + 5 FU + folinic acid

Phase 3

Colorectal Neoplasms

NSAID

Phase 3

Chronic Pain

Ritlecitinib lower dose

Phase 3

Severe Alopecia Areata

Epogen (Amgen)

Phase 3

Chronic Kidney Disease

PPSV23

Phase 3

Pneumococcal Disease

"Investigational"Auto-injector (sumatriptan succinate)

Phase 3

Migraine

VLA15

Phase 3

Lyme Borreliosis

Bococizumab (PF-04950615; RN316)

Phase 3

Hyperlipidemia

23-valent Pneumococcal Polysaccharide Vaccine

Phase 3

Pneumococcal Vaccines

BeneFIX

Phase 3

Hemophilia B

Background NSAID

Phase 3

Spondylitis, Ankylosing

VFEND® I.V., Oral

Phase 3

Candidiasis

DVS SR

Phase 3

Depressive Disorder, Major

PF-06821497

Phase 3

Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Ribociclib

Phase 3

Breast Cancer

CP-945,598

Phase 3

Obesity

Ibuprofen 400 mg caplet

Phase 3

Patient Compliance

cabergoline

Phase 3

Restless Legs Syndrome

voriconazole (Vfend)

Phase 3

Candidiasis

Ceftriaxone sodium

Phase 3

Intra-abdominal Infections

Bazedoxifene Acetate (TSE-424)

Phase 3

Osteoporosis

Bococizumab 150mg

Phase 3

Hyperlipidemia

PF-08046054

Phase 3

Non-small Cell Carcinoma

CP-690, 550

Phase 3

Psoriasis

Rimegepant 75mg Orally Disintegrating Tablets (ODT)

Phase 3

Acute Migraine

CAZ-AVI

Phase 3

Complicated Intra-Abdominal Infection

Milnacipran

Phase 3

Depression

naproxen

Phase 3

Osteoarthritis

Ibuprofen 250 mg

Phase 3

Post-surgical Pain Following Extraction of Molar Teeth

Temsirolimus

Phase 3

Renal Cell Carcinoma

Etoposide + cisplatin

Phase 3

Small Cell Lung Carcinoma

20-valent pneumococcal conjugate vaccine (20vPnC)

Phase 3

Pneumococcal Disease

Unfractionated Heparin (UFH)

Phase 3

Deep Vein Thrombosis

tolterodine tartrate

Phase 3

Overactive Bladder

bazedoxifene BZA-20

Phase 3

Postmenopause

rimegepant 75 mg ODT

Phase 3

Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps

Rapamune®

Phase 3

Kidney Disease

Pertuzumab

Phase 3

HER2 Positive Breast Cancer

Tetanus and diphtheria toxoids and acellular pertussis (Tdap) vaccine

Phase 3

Alopecia Areata

23-valent Pneumococcal Polysaccharide Vaccine (23vPS)

Phase 3

HIV Infections

Anidulafungin

Phase 3

Neutropenia

adenosine

Phase 3

Coronary Artery Disease

Varenicline Tartarate

Phase 3

Smoking Cessation

Abrocitinib 200 mg

Phase 3

Dermatitis, Atopic

Placebp

Phase 3

Respiratory Syncytial Virus

Treatment with Genotropin in different dosages

Phase 3

Growth Disorder

prinomastat

Phase 3

Brain and Central Nervous System Tumors

MEK162

Phase 3

Metastatic Colorectal Cancer

Tofacitinib 5 mg BID

Phase 3

Psoriatic Arthritis

Abrocitinib

Phase 3

Atopic Dermatitis

5 fluorouracil

Phase 3

Metastatic Colorectal Cancer

LGX818

Phase 3

Solid Tumors Harboring a BRAF V600 Mutation

vemurafenib

Phase 3

Melanoma

Genotonorm (Somatropin)

Phase 3

Fetal Growth Retardation

Xyntha

Phase 3

Hemophilia A

Zavegepant (BHV-3500)

Phase 3

Acute Migraine

Desvenlafaxine succinate sustained release 50 mg

Phase 3

Major Depressive Disorder

RESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE

Phase 3

Respiratory Syncytial Virus (RSV)

SU011248

Phase 3

Gastrointestinal Stromal Tumors

Seasonal Inactivated Influenza Vaccine

Phase 3

Respiratory Syncytial Virus

Investigator's choice

Phase 3

Lymphoma

IV Diclofenac

Phase 3

Postoperative Pain

Piperacillin/Tazobactam (Tazocin)

Phase 3

Hematologic Neoplasms

effervescent ibuprofen tablets

Phase 3

Pain

CP690,550

Phase 3

Ulcerative Colitis

Fesoterodine PR 8 mg

Phase 3

Urinary Bladder, Neurogenic

FOLFIRI regimen

Phase 3

Colorectal Cancer

clarithromycin extended release (ER)

Phase 3

Pneumonia

Xiapex

Phase 3

Dupuytren's Contracture

MTZ

Phase 3

Complicated Intra-abdominal Infection

Standard of Care

Phase 3

Macular Edema Associated With Diabetes Mellitus

vaccine-13vPnC

Phase 3

Pneumococcal Infections

PF-04965842

Phase 3

Atopic Dermatitis

ATM-AVI

Phase 3

Complicated Intra-Abdominal Infections, cIAIs

Recombinant Coagulation Factor IX (BeneFIX)

Phase 3

Hemophilia B

Ibuprofen 250 mg / Acetaminophen 500 mg

Phase 3

Fever

Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl

Phase 3

Encephalitis, Tick-Borne

Xalacom

Phase 3

Glaucoma, Open-Angle

Tanezumab 5 mg SC

Phase 3

Low Back Pain

Topical IBU twice daily

Phase 3

Ankle Injuries

PLD

Phase 3

Ovarian Cancer

Lorlatinib

Phase 3

Carcinoma, Non-Small-Cell Lung

Ibuprofen 600 mg Immediate Release/Extended Release Caplet

Phase 3

Analgesia

Clostridium difficile

Phase 3

Clostridium Difficile Associated Disease

PD 0332334

Phase 3

Generalized Anxiety Disorder

Taxotere®

Phase 3

Early Breast Cancer

PD-0332991

Phase 3

Neoplasms

UFT

Phase 3

Colon Cancer

PF-07275315 dose 1

Phase 3

Moderate to Severe Chronic Obstructive Pulmonary Disease

PF-08653944

Phase 3

Obesity

Leuprolide Open Label

Phase 3

Hormone Sensitive Prostate Cancer

MabThera®

Phase 3

Follicular Lymphoma

MenACWY-CRM

Phase 3

Meningococcal Vaccine

DA-9501

Phase 3

Sedation

rLP2086

Phase 3

Healthy

Investigational Medical Product (IMP) administered in parent study

Phase 3

Osteoarthritis

VENLAFAXINE

Phase 3

Panic Disorders

PF-05280586

Phase 3

Rheumatoid Arthritis

PG4

Phase 3

Pneumococcal Disease

Quadrivalent influenza modRNA vaccine

Phase 3

Influenza, Human

CE 0.45 mg/MPA 1.5mg

Phase 3

Endometrial Hyperplasia

voxelotor

Phase 3

Sickle Cell Disease

Standard Ibuprofen

Phase 3

Pain

23vPS

Phase 3

Vaccines, Pneumococcal Conjugate Vaccine

Solution Vehicle

Phase 3

Onychomycosis of Toenails

Levonorgestrel 90 mg/Ethinyl Estradiol 20 mg

Phase 3

Contraception

Megestrol acetate

Phase 3

Metastatic Breast Cancer

Lorazepam

Phase 3

Reflex Epilepsy, Photosensitive

RSVpreF MDV

Phase 3

Respiratory Syncytial Virus (RSV)

TBE vaccine 0.5 mL

Phase 3

Tick-Borne Encephalitis

Exubera (inhaled insulin)

Phase 3

Diabetes Mellitus, Type 2

Plant cell expressed recombinant glucocerebrosidase (prGCD)

Phase 3

Gaucher Disease

ibuzatrelvir

Phase 3

COVID-19 Infection

Inotuzumab ozogamicin

Phase 3

ACUTE LYMPHOBLASTIC LEUKEMIA

7vPnC

Phase 3

Vaccines, Pneumococcal

FLAG (fludarabine, cytarabine and G-CSF)

Phase 3

Acute Lymphoblastic Leukemia

MenABCWY

Phase 3

Meningococcal Vaccine

PF-06462700

Phase 3

Aplastic Anemia

Multivalent Group B streptococcus vaccine

Phase 3

Group B Streptococcus Infections

Infanrix hexa

Phase 3

Healthy

PF-06651600 Induction Dose

Phase 3

Alopecia Areata

C.difficile vaccine

Phase 3

Clostridioides Difficile Associated Disease

Celebrex

Phase 3

Osteoarthritis,Knee

Abemaciclib

Phase 3

Breast Cancer

propiverine

Phase 3

Urinary Bladder, Overactive

ATRA plus 6-MP and MTX

Phase 3

Leukemia, Myelocytic, Acute

Sirolimus (Rapamune®)

Phase 3

Renal Transplant

somatrogon

Phase 3

Growth Hormone Deficiency

ampicillin sodium/sulbactam sodium

Phase 3

Pneumonia, Bacterial

(PN-152,243)/PN-196,444

Phase 3

Neoplasms

Chemotherapy Regimen 1

Phase 3

Advanced Non-Small Cell Lung Cancer

ALO-02

Phase 3

Chronic Pain

exemestane (Aromasin)

Phase 3

Breast Neoplasms

somatropin - GH naïve pediatric cohort

Phase 3

Prader-Willi Syndrome

Sirolimus (RAPAMUNE)

Phase 3

Graft vs Host Disease

Meningococcal group C polysaccharide conjugate vaccine

Phase 3

Neisseria Meningitidis

Moxifloxacin

Phase 3

Chronic Bronchitis

binodenoson

Phase 3

Coronary Artery Disease

Itraconazole

Phase 3

Antifungal Prophylaxis of Invasive Fungal Infections

bivalent rLP2086

Phase 3

Meningococcal Infection

Inhaled human insulin

Phase 3

Diabetes Mellitus, Type 1

Hib

Phase 3

Pneumococcal Infections

Experimental 20-valent pneumococcal conjugate vaccine (20vPnC)

Phase 3

Pneumococcal Disease

Elotuzumab

Phase 3

Multiple Myeloma

FDC IBU/APAP 250 mg/500 mg

Phase 3

Pain

Matching vehicle control

Phase 3

Dermatitis, Atopic

Ritlecitinib 50 mg

Phase 3

Chronic Spontaneous Urticaria

Avelumab

Phase 3

Urothelial Cancer

DVS-233 SR (desvenlafaxine sustained release )

Phase 3

Major Depressive Disorder

Insulin Lispro

Phase 3

Diabetes Mellitus

Cyclosporine A

Phase 3

Renal Transplantation

13 valent pneumococcal conjugate vaccine with Polysorbate 80

Phase 3

Vaccines, Pneumococcal

Meropenem

Phase 3

Complicated Intra-abdominal Infections

MET097

Phase 3

Obesity

RSVpreF (Group 1)

Phase 3

RSV

Imipenem-cilastatin

Phase 3

Skin Infection

Diclofenac

Phase 3

Spondylitis, Ankylosing

Pediacel

Phase 3

Vaccines, Pneumococcal

Pemetrexed/Cisplatin

Phase 3

NSCLC (Non-small Cell Lung Cancer)

bazedoxifene 20 mg/ conjugated estrogens 0.45 mg

Phase 3

Menopause

desvenlafaxine succinate (DVS) SR

Phase 3

Vasomotor Symptoms

PF-06823859

Phase 3

Myositis

Ritlecitinib

Phase 3

Stable Nonsegmental Vitiligo

Nonacog alfa

Phase 3

Hemophilia B

Novel Ibuprofen

Phase 3

Pain

AG-013736

Phase 3

Carcinoma, Pancreatic Ductal

Epoetin Hospira Arm

Phase 3

Chronic Kidney Disease (CKD)

Imipenem

Phase 3

Bacterial Pneumonia

marstacimab

Phase 3

Hemophilia A

Bosutinib

Phase 3

Polycystic Kidney, Autosomal Dominant

Inhaled Insulin

Phase 3

Asthma

Rimegepant

Phase 3

Acute Migraine

Bazedoxifene/Conjugate Estrogens (CE)

Phase 3

Endometrial Hyperplasia

7-valent Pneumococcal Conjugate Vaccine

Phase 3

Pneumococcal Infection

Modified Bolus 5-FU/LV with Irinotecan

Phase 3

Colorectal Neoplasms

varenicline (CP-526,555)

Phase 3

Smoking Cessation

Tigecycline

Phase 3

Gram-Positive Bacterial Infections

fesoterodine fumarate

Phase 3

Overactive Bladder

SPM 907

Phase 3

Overactive Bladder Syndrome

Somatropin

Phase 3

Endocrine System Diseases

Parecoxib Sodium/Valdecoxib

Phase 3

Pain

Palbociclib

Phase 3

Breast Cancer

DVS-233

Phase 3

Menopause

Tisotumab Vedotin

Phase 3

Cervical Cancer

13-valent pneumococcal conjugate vaccine

Phase 3

Pneumococcal Vaccines

levonorgestrel/ethinyl estradiol

Phase 3

Menstruation Disturbances

Ritlecitinib higher dose

Phase 3

Severe Alopecia Areata

PF-07321332

Phase 3

COVID-19

AN2690 Topical Solution, 5%

Phase 3

Onychomycosis of Toenails

AN2728 Topical Ointment, 2%

Phase 3

Dermatitis, Atopic

Pentavac

Phase 3

Vaccines, Pneumococcal

Encorafenib

Phase 3

BRAF V600E-mutant Metastatic Colorectal Cancer

20-valent pneumococcal conjugate vaccine

Phase 3

Pneumococcal Disease

Talazoparib with enzalutamide

Phase 3

mCRPC

Group C Meningococcal Polysaccharide-Tetanus Toxoid Conjugate Vaccine (GCMP-TT)

Phase 3

Meningitis, Meningococcal

Genotropin

Phase 3

Idiopathic Short Stature

Zavegepant

Phase 3

Migraine

[S,S]-Reboxetine

Phase 3

Fibromyalgia

PF-06651600

Phase 3

Active Non-segmental Vitiligo

Taliglucerase alfa

Phase 3

Gaucher Disease

PF-06410293

Phase 3

Rheumatoid Arthritis

linezolid

Phase 3

Febrile Neutropenia

Group C Meningococcal Polysaccharide-Tetansu Toxoid Conjugate (MenC-TT) vaccine and 7-valent Pneumococcal CRM197-conjugate vaccine (PCV7)

Phase 3

Neisseria Meningitidis (Bacterial Meningitis)

Desvenlafaxine succinate sustained-release (DVS SR)

Phase 3

Depression

Epirubicin with Cyclophosphamide, followed by a Taxane

Phase 3

Adenocarcinoma

Ceftazidime-avibactam

Phase 3

Complicated Intra-abdominal Infection

talazoparib plus enzalutamide

Phase 3

Prostate Cancer

Ibuprofen/Caffeine

Phase 3

Pain

PF-06947386

Phase 3

Complicated Intra-abdominal Infection

tucatinib

Phase 3

HER2-positive Breast Cancer

CP-690,550

Phase 3

Crohn's Disease

Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)

Phase 3

Encephalitis, Tick-borne

Bococizumab (PF-04950615;RN316)

Phase 3

Hyperlipidemia

ponsegromab

Phase 3

Non-small Cell Lung Cancer

Dexmedetomidine

Phase 3

Sedation

DVS-233 SR

Phase 3

Major Depressive Disorder

Dacomitinib (PF-00299804)

Phase 3

Non-Small Cell Lung Cancer

Genotropin (PN-180,307) Somatropin

Phase 3

Infant, Small for Gestational Age

sumanirole

Phase 3

Parkinson Disease

UK-390,957

Phase 3

Ejaculation

torcetrapib/atorvastatin

Phase 3

Hyperlipidemia

RSVpreF

Phase 3

RSV Infection

disitamab vedotin

Phase 3

Urothelial Carcinoma

Fesoterodine

Phase 3

Overactive Bladder Syndrome

Nimenrix

Phase 3

Meningococcal Vaccine

7-Valent Pneumococcal Conjugate Vaccine (7vPnC)

Phase 3

Healthy Subjects

Meningococcal vaccine GSK134612

Phase 3

Infections, Meningococcal

13-valent pneumococcal conjugate vaccine (13vPnC)

Phase 3

Healthy Subjects

Moroctocog alfa (AF-CC)

Phase 3

Hemophilia A

lecozotan SR (SRA-333)

Phase 3

Alzheimer Disease

tanezumab 10 mg

Phase 3

Osteoarthritis

Desvenlafaxine Succinate Sustained-Release 10mg

Phase 3

Major Depressive Disorder

7 valent pneumococcal conjugate vaccine

Phase 3

Vaccines, Pneumococcal

Inhaled human insulin (EXUBERA™)

Phase 3

Diabetes Mellitus, Type 2

Tolterodine ER

Phase 3

Overactive Bladder

Fragmin

Phase 3

Diabetic Foot Ulcer

Tafamidis

Phase 3

Transthyretin (TTR) Amyloid Cardiomyopathy

Interferon-alfa

Phase 3

Carcinoma, Renal Cell

tanezumab

Phase 3

Arthritis

13vPnC

Phase 3

Vaccines, Pneumococcal Conjugate Vaccine

Rifabutin

Phase 3

Mycoses

endocrine-modulating drug therapy

Phase 3

Prostate Cancer

Ibuprofen Sodium

Phase 3

Pain

ceftazidim-avibactam (CAZ-AVI, experimental product)

Phase 3

Nosocomial Pneumonia (NP)

leflunomide

Phase 3

Prostate Cancer

Cyclosporin or tacrolimus

Phase 3

Graft Rejection

Edotecarin

Phase 3

Breast Neoplasms

Ceftaroline fosamil

Phase 3

Complicated Skin and Soft Tissue Infection

Levonorgestrel 90 mg and Ethinyl Estradiol 20 mg

Phase 3

Oral Contraceptive

Enbrel (etanercept)

Phase 3

Ankylosing Spondylitis

Zmax

Phase 3

Otitis Media

Venlafaxine ER

Phase 3

Panic Disorder

ARV-471

Phase 3

Advanced Breast Cancer

ARV-471 (PF-07850327)

Phase 3

Breast Cancer

valdecoxib

Phase 3

Pain

Havrix (HAV)

Phase 3

Meningococcal Vaccine

PF-08653945

Phase 2

Overweight

PF-05089771 150 mg

Phase 2

Diabetic Neuropathy, Painful

Carfilzomib, proteasome inhibitor; intravenous

Phase 2

Advanced Multiple Myeloma

PF-06826647

Phase 2

Psoriasis

PF-06882961 (Cohorts 1 and 2)

Phase 2

Obesity

PF-04383119

Phase 2

Cystitis, Interstitial

Bazedoxifene

Phase 2

Postmenopausal Osteoporosis

PF-05221304

Phase 2

Nonalcoholic Fatty Liver Disease

ARRY-520, KSP(Eg5) inhibitor; intravenous

Phase 2

Multiple Myeloma

FOLFIRI (Irinotecan, leucovorin, 5-fluorouracil [5FU])

Phase 2

Colorectal Neoplasms

PF-07850327, ARV-471, vepdegestrant

Phase 2

Locally Advanced or Metastatic ER+ HER2- Breast Cancer

CP-690-550

Phase 2

Arthritis, Rheumatoid

SU-011,248

Phase 2

Kidney Neoplasms

PF-06835919

Phase 2

Non-alcoholic Steatohepatitis

TMI-005

Phase 2

Rheumatoid Arthritis

Multivalent Pneumococcal Vaccine - Formulation 1

Phase 2

Pneumococcal Disease

0.04 mg/kg CpG 7909

Phase 2

Carcinoma, Breast

PF-04217329 - Lowest Dose

Phase 2

Primary Open-Angle Glaucoma

Tygacil

Phase 2

Bacterial Infections

(Part C) MET097

Phase 2

Obesity and Overweight

axitinib

Phase 2

Carcinoma, Non-Small Cell Lung

Influenza ModRNA Vaccine

Phase 2

Influenza, Human

PF-06291874

Phase 2

Diabetes Mellitus, Type II

IMA-638

Phase 2

Asthma

Group B streptoccous 6-valent polysaccharide conjugate vaccine (GBS6)

Phase 2

Group B Streptococcal Infections

SCA-136 (200 mg)

Phase 2

Schizophrenia

AN2728 ointment, 2%

Phase 2

Psoriasis

PF-06882961

Phase 2

Diabetes

PF-00489791

Phase 2

Diabetic Nephropathies

PF-07104091 monotherapy dose escalation

Phase 2

Small Cell Lung Cancer

UK-453, 061

Phase 2

HIV-1

meningococcal B rLP2086 vaccine.

Phase 2

Meningitis, Meningococcal

ARRY-502, CRTh2 antagonist; oral

Phase 2

Asthma

Levonorgestrel

Phase 2

Ovulation

Formulation A

Phase 2

Respiratory Tract Infections

Candidate 1: PF-07915234: VZV modRNA Powder for Suspension for Injection

Phase 2

Shingles

CPG 7909 Injection

Phase 2

Carcinoma, Melanoma

NR2B NMDA Antagonist CP-101,606 (traxoprodil)

Phase 2

Parkinson's Disease

PF-04383119 (tanezumab)

Phase 2

Osteoarthritis, Knee

Multivalent

Phase 2

Pneumococcal Infections

Filibuvir

Phase 2

Hepatitis

Combination 1

Phase 2

Carcinoma, Renal Cell

Tamsulosin

Phase 2

Prostatic Hyperplasia

AN2728

Phase 2

Psoriasis

Vupanorsen

Phase 2

Dyslipidemias

AN2898 ointment, 1%

Phase 2

Dermatitis, Atopic

IMA-638 is a biologic

Phase 2

Asthma

CPG 7909

Phase 2

Carcinoma, Non-Small Cell Lung

PF-00592379

Phase 2

Impotence

sulopenem and PF-03709270

Phase 2

Pneumonia, Bacterial

ARRY-438162, MEK inhibitor; oral

Phase 2

Rheumatoid Arthritis

ACC-001

Phase 2

Alzheimer's Disease

FOLFIRI (The combination regimen of Irinotecan, l-Leucovorin and 5-Fluorouracil)

Phase 2

Unresectable or Metastatic Colorectal Cancer

Samuraciclib

Phase 2

Breast Cancer

SKI-606 (Bosutinib)

Phase 2

Chronic Myelogenous Leukemia

Herceptin®

Phase 2

Carcinoma, Metastatic Breast

PF-06823859 low

Phase 2

Dermatomyositis

Peg-Intron

Phase 2

Hepatitis C

PF-06700841

Phase 2

Psoriatic Arthritis

Tofacitinib ointment 20mg/g

Phase 2

Dermatitis, Atopic

Filanesib, KSP (Eg5) inhibitor; intravenous

Phase 2

Advanced Multiple Myeloma

vepdegestrant

Phase 2

Breast Cancer

PF-04236921

Phase 2

Crohn's Disease

Enfortumab Vedotin

Phase 2

Urothelial Cancer

WNT974

Phase 2

Metastatic Colorectal Cancer

RV521

Phase 2

Respiratory Syncytial Virus Infections

PF-04494700 (TTP488)

Phase 2

Diabetic Nephropathy

Irinotecan plus capecitabine

Phase 2

Carcinoma, Hepatocellular

Anrukinzumab

Phase 2

Colitis, Ulcerative

PF-00734200 30 mg QD

Phase 2

Diabetes Mellitus, Type 2

Tasocitinib plus Methotrexate

Phase 2

Rheumatoid Arthritis

PH-797804

Phase 2

Pulmonary Disease, Chronic Obstructive

CCI-779

Phase 2

Multiple Sclerosis, Relapsing-Remitting

sunitinib malate dose escalation

Phase 2

Gastrointestinal Stromal Tumors

PF-04634817

Phase 2

Diabetic Nephropathy

QS-21

Phase 2

Alzheimer Disease

PF-07868489

Phase 2

Pulmonary Arterial Hypertension

ACC-001 + QS-21

Phase 2

Alzheimer Disease

PF-06835375

Phase 2

Primary Immune Thrombocytopenia

exemestane (Aromasin®)

Phase 2

Breast Neoplasms

SS-RBX

Phase 2

Urinary Incontinence, Stress

bapineuzumab

Phase 2

Alzheimer Disease

cytarabine.

Phase 2

Acute Myeloid Leukemia

PELITREXOL/AG-2037

Phase 2

Colorectal Neoplasms

Elranatamab (PF-06863135)

Phase 2

Multiple Myeloma

Torisel

Phase 2

Adenocarcinoma

Anti-Beta Interferon (PF-06823859)

Phase 2

Dermatomyositis

ILV-094

Phase 2

Rheumatoid Arthritis

PF-07220060 + PF-07104091 combination dose escalation

Phase 2

Breast Cancer

EXC 001

Phase 2

Scar Prevention

SAM-531

Phase 2

Alzheimer Disease

ARRY-334543, EGFR/ErbB2 inhibitor; oral

Phase 2

Advanced Cancer

PF-04937319 - 3mg

Phase 2

Type 2 Diabetes Mellitus

C. difficile vaccine (previously studied formulation).

Phase 2

Clostridoides Difficile Associated Disease

Kaletra

Phase 2

HIV Infections

CP-778,875

Phase 2

Dyslipidemia

AN2690, 5%

Phase 2

Distal, Subungual Onychomycosis

CP-533, 536

Phase 2

Tibial Fractures

SBI-087

Phase 2

Active Rheumatoid Arthritis

BGJ398

Phase 2

Melanoma

PF-04494700 - Low Dose Arm

Phase 2

Alzheimer Disease

lecozotan SR

Phase 2

Alzheimer Disease

PF-05089771

Phase 2

Postoperative Dental Pain

rhBMP-2/CPM

Phase 2

Fractures

BYL719

Phase 2

Colorectal Cancer

CE-224,535

Phase 2

Arthritis, Rheumatoid

BNT162b2 (Omi XBB.1.5)/RIV

Phase 2

Influenza, Human

MYO-029

Phase 2

Becker Muscular Dystrophy

MultiStem low dose

Phase 2

Colitis, Ulcerative

PF-00610355

Phase 2

Pulmonary Disease, Chronic Obstructive

PF-04937319 10 mg

Phase 2

Diabetes Mellitus, Type 2

SRA-333

Phase 2

Alzheimer's Disease

SPK-9001

Phase 2

Hemophilia B

CP-866,087

Phase 2

Alcoholism

CI-1040

Phase 2

Colorectal Neoplasms

PF-04171327 10 mg

Phase 2

Rheumatoid Arthritis

MET233 and MET097

Phase 2

Obesity and Obesity-related Medical Conditions

ARRY-371797, p38 inhibitor; oral

Phase 2

LMNA-Related Dilated Cardiomyopathy

PF-04950615 (RN316)

Phase 2

Hypercholesterolemia

CP-751,871

Phase 2

Prostatic Neoplasms

CPG10101

Phase 2

Hepatitis, Chronic Active

PF-06372865

Phase 2

Chronic Low Back Pain

PF-04360365 0.1 mg/kg

Phase 2

Alzheimer's Disease

RSV Vaccine

Phase 2

Respiratory Tract Infection

Sunitinib malate (SU011248)

Phase 2

Gastrointestinal Stromal Tumors

PF-04383119 (RN624)

Phase 2

Low Back Pain

dalteparin

Phase 2

Venous Thromboembolism

PF-04457845

Phase 2

Osteoarthritis, Knee

Methotrexate plus ERB-041 for 12 weeks

Phase 2

Rheumatoid Arthritis

Dacomitinib

Phase 2

Non-small Cell Lung Cancer

PF-00232798

Phase 2

HIV

SB-525 (PF-07055480)

Phase 2

Hemophilia A

PF-07817883

Phase 2

SARS-CoV-2 Infection

NMDA Antagonist, CP-101,606 (traxoprodil)

Phase 2

Depressive Disorder, Major

Naproxen + PH-797804

Phase 2

Osteoarthritis

CE-326,597 100 mg QD

Phase 2

Weight Management

PF-08049820

Phase 2

Atopic Dermatitis

Letrozole / Temsirolimus (CCI-779)

Phase 2

Breast Neoplasms

CI-1033

Phase 2

Breast Neoplasms

Sunitinib (SU011248)

Phase 2

Liver Neoplasms

Low Dose PF-07328948

Phase 2

Heart Failure

SU011248 (sunitinib)

Phase 2

Carcinoma, Renal Cell Metastasis

MRE0094

Phase 2

Foot Ulcer, Diabetic

PF-00868554

Phase 2

Hepatitis C

Rapamune® (Sirolimus)

Phase 2

Kidney Transplantation

tacedinaline

Phase 2

Pancreatic Cancer

SD-6010

Phase 2

Osteoarthritis

CP-690,550 Ointment 1

Phase 2

Psoriasis

AN2690

Phase 2

Onychomycosis

150 mg PF-04991532

Phase 2

Diabetes, Type 2

inotuzumab ozogamicin (CMC-544)

Phase 2

Lymphoma, B-Cell

Repevax

Phase 2

Meningococcal Vaccine

CI 1033

Phase 2

Lung Neoplasms

Open

Phase 2

Chronic Kidney Disease

Vaccine

Phase 2

Meningococcal Vaccine

Meningococcal C

Phase 2

Meningitis, Meningococcal

PF-06838435 (formerly SPK-9001)

Phase 2

Hemophilia B

PF-03654746

Phase 2

Excessive Daytime Sleepiness

PF-00217830

Phase 2

Schizophrenia

EKB-569

Phase 2

Colorectal Neoplasms

AN2728 Ointment Vehicle

Phase 2

Psoriasis

Vascular Endothelial Growth Factor Receptor [VEGFR] and Platelet-Derived Growth Factor Receptor [PDGFR] inhibitor

Phase 2

Kidney Neoplasms

Ceftazidime -avibactam

Phase 2

Complicated Urinary Tract Infections

CP-690,550 + methotrexate

Phase 2

Rheumatoid Arthritis

RN624

Phase 2

Neuralgia, Postherpetic

PD-217,014

Phase 2

Irritable Bowel Syndrome

PD 0348292

Phase 2

Venous Thrombosis

UK-453,061

Phase 2

HIV-1

Axitinib [AG-013736]

Phase 2

Melanoma

PF-06835919 Low Dose

Phase 2

Non-alcoholic Fatty Liver Disease

CP-526,555 (varenicline)

Phase 2

Smoking Cessation

PF-05221304 Monotherapy

Phase 2

Non-Alcoholic Fatty Liver Disease (NAFLD)

MET233

Phase 2

Obesity and Overweight

PBO

Phase 2

Hypercholesterolemia

BAT

Phase 2

Gram-negative Bacterial Infections

PF-00446687

Phase 2

Erectile Dysfunction

Tisotumab vedotin (HuMax-TF-ADC)

Phase 2

Ovary Cancer

ERB-041

Phase 2

Endometriosis

PF-06650833

Phase 2

Acne Inversa

AG-013736 (Axitinib)

Phase 2

Acute Myeloid Leukemia (AML)

UK-369,003

Phase 2

Prostatic Hyperplasia

LEE011

Phase 2

Locally Advanced or Metastatic NRAS Mutant Melanoma

CP-547,632

Phase 2

Ovarian Neoplasms

Esreboxetine

Phase 2

Fibromyalgia

Staphylococcus aureus 4-antigen vaccine

Phase 2

Staphylococcal Infections

PF-04494700

Phase 2

Alzheimer's Disease

mPnC candidate

Phase 2

Healthy Participants

15-valent pneumococcal conjugate vaccine (PCV15)

Phase 2

Pneumococcal Disease

CP-690,550 Eye drops

Phase 2

Dry Eye Syndromes

mIRV

Phase 2

Influenza, Human

Tofimilast

Phase 2

Asthma

PF-03654764

Phase 2

Allergic Rhinitis

PF-00734200 10 mg QD

Phase 2

Diabetes Mellitus, Type 2

Tick-borne Encephalitis Vaccine

Phase 2

Tick-borne Encephalitis

PF-02545920

Phase 2

Huntington's Disease

Sumatriptan

Phase 2

Migraine

25 mg PF-04991532

Phase 2

Diabetes Mellitus, Type 2

PF-07220060 CDK4 inhibitor

Phase 2

Advanced or Metastatic Breast Cancer

Ibuprofen/acetaminophen

Phase 2

Pain

Atomoxetine

Phase 2

Attention Deficit Disorder With Hyperactivity

MAC-321

Phase 2

Colorectal Neoplasms

Pediatric HAV vaccine

Phase 2

Meningococcal B Disease

RN624 (PF-04383119)

Phase 2

Osteoarthritis

Elranatamab + Nirogacestat

Phase 2

Multiple Myeloma

Dexmedetomidine, midazolam; fentanyl

Phase 2

Intubated and Mechanically Ventilated Pediatric Subjects

CP- 690 550

Phase 2

Ulcerative Colitis

PF-04191834

Phase 2

Asthma

PF-04171327

Phase 2

Rheumatoid Arthritis

rLP2086 and Gardasil

Phase 2

Vaccines

Anti-NGF AB

Phase 2

Neoplasms

PF-04360365 10 mg/kg

Phase 2

Alzheimer's Disease

active comparator

Phase 2

Pulmonary Disease, Chronic Obstructive

AN2690 Solution, 5.0%

Phase 2

Onychomycosis

PF-04136309

Phase 2

Osteoarthritis, Knee

tofacitinib ointment 20 mg/g

Phase 2

Psoriasis Vulgaris

Sitexsentin sodium

Phase 2

Diastolic Heart Failure

PF-04236921 SC injection

Phase 2

Crohn's Disease

Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR)

Phase 2

Depression

PF-07275315

Phase 2

Asthma

ARRY-371797, p38 inhibitor, oral

Phase 2

LMNA-Related Dilated Cardiomyopathy

ALO-01

Phase 2

Healthy

vabicaserin

Phase 2

Schizophrenia

Capravirine

Phase 2

Human Immunodeficiency Virus

Bivalent rLP2086 Vaccine

Phase 2

MENINGOCOCCAL INFECTION

Combination Agent 1

Phase 2

Advanced/Metastatic Non-Small Cell Lung Cancer

PF-04217329

Phase 2

Glaucoma, Open-Angle

Tanezumab 20 mg IV

Phase 2

Low Back Pain

Investigational drug

Phase 2

Carcinoma, Non-Small-Cell Lung

SU011248 capsule

Phase 2

Carcinoma, Renal Cell

Crisaborole ointment 2% BID

Phase 2

Dermatitis, Atopic

Part A: ATM-AVI Single Dose, Cohorts 1-4

Phase 2

Gram-negative Bacterial Infection

UK0369,003

Phase 2

Impotence

AN2728 Topical Ointment, 2% QD

Phase 2

Dermatitis, Atopic

PF-04449913

Phase 2

Acute Myeloid Leukemia

Crisaborole ointment 2%

Phase 2

Atopic Dermatitis

PF-06700841 15 mg

Phase 2

Systemic Lupus Erythematosus

Ponezumab

Phase 2

Cerebral Amyloid Angiopathy

Tofacitinib 2 mg

Phase 2

Ankylosing Spondylitis

maplirpacept (PF-07901801)

Phase 2

Diffuse Large B-Cell Lymphoma

PF-07264660

Phase 2

Atopic Dermatitis

PF-3512676

Phase 2

Lymphoma, T-Cell, Cutaneous

HSP-130

Phase 2

Non-metastatic Breast Cancer

Chemotherapy Regimen 2

Phase 2

Carcinoma

Tanezumab 10 mg IV

Phase 2

Neoplasm Metastasis

MET097 Injection

Phase 2

Obesity in Diabetes

PF-07038124 ointment

Phase 2

Atopic Dermatitis

SU014813

Phase 2

Breast Neoplasms

Tdap

Phase 2

Pneumococcal Infections

rLP2086 + MCV4 + Tdap

Phase 2

Vaccines

(CP-6890,550) Tofacitinib

Phase 2

Plaque Psoriasis

PF-06473871

Phase 2

Reduction of Hypertrophic Skin Scarring

PF-04447943

Phase 2

Alzheimer's Disease

ACC-001(3µg) + QS21

Phase 2

Alzheimer Disease

PD 0332991

Phase 2

Breast Cancer

AG013736

Phase 2

Thyroid Neoplasms

PF-06463922

Phase 2

ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC

Sunitinib Malate Continuous Daily Dosing

Phase 2

Carcinoma, Renal Cell

meningococcal B rLP2086 vaccine candidate

Phase 2

Meningitis, Meningococcal

Statin

Phase 2

Hypercholesterolemia

NXL104/ceftazidime

Phase 2

Complicated Urinary Tract Infection

Recombinant Human Interleukin-11 (rhIL-11)

Phase 2

Crohn Disease

sitaxsentan (Thelin)

Phase 2

Cardiac Surgery Subjects

PF-06865571

Phase 2

Nonalcoholic Steatohepatitis

ACC-001 3 μg/ QS-21 50 μg

Phase 2

Alzheimer's Disease

PF-07038124 ointment 0.01%

Phase 2

Atopic Dermatitis

Vaccine Candidate #1

Phase 2

Healthy Adults

PF-07976016

Phase 2

Obesity

PF-00299804

Phase 2

Carcinoma, Non Small Cell Lung

CP-751, 871

Phase 2

Colorectal Neoplasm

852A

Phase 2

Melanoma

PD 0200390

Phase 2

Nonrestorative Sleep

PF-610,355

Phase 2

Asthma

Allegra

Phase 2

Allergic Rhinitis

Combination [RSVpreF+BNTb162b2]

Phase 2

Healthy Participants

PD-0299685

Phase 2

Hot Flashes

AG-013726

Phase 2

Colorectal Neoplasms

CP-690,550 Vehicle

Phase 2

Dry Eye Syndromes

Mylotarg (gemtuzumab ozogamicin) Injection

Phase 2

Acute Myelogenous Leukemia

EXC 001 (currently called PF-06473871)

Phase 2

Reduction in Severity of Skin Scarring

AN2690, 2.5%

Phase 2

Distal, Subungual Onychomycosis

PD 0299685 at 15mg BID

Phase 2

Interstitial Cystitis

alopecia areata, nonscarring alopecia (NSV)

1 drug in this indication

nonsegmental vitiligo

1 drug in this indication

Overweight

1 drug in this indication

Renal Transplantation

1 drug in this indication

alopecia areata, non-scarring alopecia (NSV)

1 drug in this indication

vitiligo

1 drug in this indication

Bladder cancer

1 drug in this indication

weight-loss

1 drug in this indication

COVID-19

1 drug in this indication

oncology

1 drug in this indication

Major Depressive Disorder

1 drug in this indication

Diabetes Mellitus

1 drug in this indication

HRR-altered metastatic castration-resistant prostate cancer

1 drug in this indication

Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)

📑
Catalyst DossierPRO
The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.
→
Catalyst Verdict

Full breakdown — the signals behind the verdict

Market-Implied Move
Regulatory Approvals

Frequently asked questions

What is in PFIZER's drug pipeline?→

CatalystAlert tracks 670 drug candidates in PFIZER's (PFE) pipeline across Phase 3, Phase 2. Its lead program is FSME-IMMUN NEW 0.25 ml (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is PFIZER's next FDA catalyst?→

PFIZER's (PFE) next tracked catalyst is a Phase 2 expected August 23, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track PFE biotech catalysts?→

Add PFE to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow PFIZER's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply